CG
IRWD icon

Cutler Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cutler Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,600
Closed -$27K – 4957
2020
Q2 		$27K Buy
7,600
+100
+1% +$1.02K ﹤0.01% 2170
2020
Q1 		$23K Buy
+7,500
New +$88.2K ﹤0.01% 2204
2018
Q3 		– Sell
-2,985
Closed -$2K – 4383
2018
Q2 		$2K Buy
+2,985
New +$44.2K ﹤0.01% 3582
2016
Q2 		– Sell
-3,940
Closed -$2K – 6942
2016
Q1 		$2K Buy
+3,940
New +$32.5K ﹤0.01% 5586

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cutler Group's IRWD Position: Q3 2020 in Review

Cutler Group sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 5,300 shares — an estimated $54K sold.

Cutler Group first reported a position in IRWD in Q4 2015 and held it in 7 quarters. The position peaked at $54K in Q2 2020. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

  • Cutler Group reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Cutler Group sold 5,300 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $54K.
  • Cutler Group first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 7 quarters.
  • Cutler Group's Ironwood Pharmaceuticals position peaked at $54K in Q2 2020.
  • 190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on Cutler Group's 13F filing for Q3 2020, filed 27 Oct 2020.